Moclobemide is a monoamine oxidase (MAO) inhibitor used to treat certain types of mental depression. It works by blocking the action of a chemical substance known as monoamine oxidase (MAO) in the nervous system.
Moclobemide Tablet Market contains market size and forecasts of Moclobemide Tablet in global, including the following market information:
- Global Moclobemide Tablet Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Moclobemide Tablet Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Moclobemide Tablet companies in 2021 (%)
The global Moclobemide Tablet market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
150mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Moclobemide Tablet include Roche, Viatris, Apotex, Arrow Pharmaceuticals, Sandoz and Lunan Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Moclobemide Tablet manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Moclobemide Tablet Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Moclobemide Tablet Market Segment Percentages, by Type, 2021 (%)
Global Moclobemide Tablet Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Moclobemide Tablet Market Segment Percentages, by Application, 2021 (%)
Global Moclobemide Tablet Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Moclobemide Tablet Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Moclobemide Tablet revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Moclobemide Tablet revenues share in global market, 2021 (%)
- Key companies Moclobemide Tablet sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Moclobemide Tablet sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Roche
- Viatris
- Apotex
- Arrow Pharmaceuticals
- Sandoz
- Lunan Pharmaceutical